Cerebral Palsy: Short-burst Interval Training

June 20, 2019 updated by: Kristie Bjornson, Seattle Children's Hospital

Muscle Performance and Walking in Cerebral Palsy: Short-burst Interval Training

This study examines the effect of short burst interval treadmill training in ambulatory children with cerebral palsy. Half the sample will receive 20 sessions of training over 4 weeks, while half will receive the training over 10 weeks.

Study Overview

Detailed Description

Ambulatory children with cerebral palsy (CP) experience activity limitations which negatively influence their ability to physically participate in day to day life. Therefore, these children are at greater risk for inactivity and functional decline with age. In contrast, typically developing (TD) children engage in short bursts of intense physical activity interspersed with varying intervals of low and moderate intensity within their natural environment. These physical activity patterns are very different from adult patterns Despite these inherent differences, locomotor treadmill training (LTT) protocols designed to improve walking activity in children with CP simulate adult protocols, consisting of continuous low to moderate walking endurance activity. Body weight supported or robot assisted LTT is based on the underlying premise of modifying neural circuitry via spinal pathways. However, this type of training has not been shown to be more effective than other comparable interventions and presents with significant fiscal and logistical barriers to clinical translation.

This study will determine the effect of short-burst interval LTT without body weight support on the primary outcomes of walking performance and capacity and the secondary outcomes of day-to-day mobility based participation in children with CP with functional walking limitations. To identify key muscular mechanisms associated with improved walking mobility, the investigators will examine the effects of short-burst interval LTT on quadriceps muscle performance and architecture. Secondarily, the study team will collect preliminary data on two LTT dosing frequencies.

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Washington
      • Seattle, Washington, United States, 98115
        • Seattle Children's Research Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 12 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Ambulatory children with cerebral palsy Spasticity primary movement disorder Bilateral motor impairment (Diplegia) Gross Motor Function Classification System Levels II and III

Exclusion Criteria:

  • undergone orthopedic or neurosurgery less than 12 months prior injection therapies (phenol, botulinum toxin) less than 3 months prior

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Short burst Interval Treadmill Training High Frequency
Participants receive short burst interval treadmill training for a total of 20 sessions. They are randomized to receive it either 5x/week for 4 weeks
SBLTT consists of interval training consisting of short-bursts (30 seconds) of vigorous intensity locomotor treadmill training (LTT) alternating with low to moderate intensity LTT.,
ACTIVE_COMPARATOR: Short Burst Interval Treadmill Training Low Frequency
Participants receive short burst interval treadmill training for a total of 20 sessions. They are randomized to receive it either 2x/week for 10 weeks
SBLTT consists of interval training consisting of short-bursts (30 seconds) of vigorous intensity locomotor treadmill training (LTT) alternating with low to moderate intensity LTT.,

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Walking Performance High Versus Low Frequency SBLTT Groups
Time Frame: Change from baseline to immediately post SBLTT
Average stride per day as measured by StepWatch accelerometry. StepWatch accelerometer stride counts per day ( minimum of 8 hrs/day wearing time) were averaged a crossed 5 days (4 weekdays and 1 weekend day) to create Average Strides/day variable
Change from baseline to immediately post SBLTT
Change in Community Walking Performance Intensity High Versus Low Frequency SBLTT Groups
Time Frame: Change from baseline to immediately post SBLTT
Average Strides/day > 30 strides/min as measured by StepWatch accelerometry High Versus Low Frequency SBLTT Groups
Change from baseline to immediately post SBLTT
Change in Walking Capacity High Versus Low Frequency SBLTT Groups
Time Frame: Change from baseline to immediately post SBLT.
Self selected walking speed as measured by 10 meter walk test High Versus Low Frequency SBLTT Groups
Change from baseline to immediately post SBLT.
Change in Walking Endurance- High Versus Low Frequency SBLTT Groups
Time Frame: Change from baseline to immediately post SBLTT
Distance walked during the One Minute Walk Test High Versus Low Frequency SBLTT Groups
Change from baseline to immediately post SBLTT

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Muscle Performance -Power High Versus Low Frequency SBLTT Groups
Time Frame: Change from baseline to 6 weeks post SBLTT
Knee extensor muscle power - isotonic muscle power as measured by Biodex testing High Versus Low Frequency SBLTT Groups
Change from baseline to 6 weeks post SBLTT
Change in Muscle Performance - Strength High Versus Low Frequency SBLTT Groups
Time Frame: Change from baseline to immediately post SBLTT
Knee extensor muscle strength - isometric muscle strength as measured by Biodex testing High Versus Low Frequency SBLTT Groups
Change from baseline to immediately post SBLTT
Change in Muscle Architecture-High Versus Low Frequency SBLTT Groups
Time Frame: Change from baseline to immediately post SBLTT
Rectus femoris mid thigh cross-sectional area as measured by 2D B Mode Ultrasound High Versus Low Frequency SBLTT Groups
Change from baseline to immediately post SBLTT
Change in Muscle Architecture-hypertrophy High Versus Low Frequency SBLTT Groups
Time Frame: Change from baseline to immediately post SBLTT
Rectus femoris mid thigh fascicle length as measured by 2D B Mode Ultrasound High Versus Low Frequency SBLTT Groups
Change from baseline to immediately post SBLTT

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: James Hendricks, PhD, Seattle Children's Research Institute

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 1, 2014

Primary Completion (ACTUAL)

July 31, 2016

Study Completion (ACTUAL)

July 31, 2016

Study Registration Dates

First Submitted

December 6, 2017

First Submitted That Met QC Criteria

December 11, 2017

First Posted (ACTUAL)

December 14, 2017

Study Record Updates

Last Update Posted (ACTUAL)

July 10, 2019

Last Update Submitted That Met QC Criteria

June 20, 2019

Last Verified

June 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • R21HD077186 (NIH)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy Spastic Diplegia

Clinical Trials on Short Burst Interval Locomotor Treadmill Training (SBLTT)

Subscribe